Impact of pregnancy liver condition on baby's breathing
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study looks at how a pregnancy liver condition (intrahepatic cholestasis) affects the baby's breathing after birth. It compares newborns whose mothers had this condition (and took medication for it) with newborns whose mothers did not have any liver issues during pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a liver condition of pregnancy called intrahepatic cholestasis (bile acids over 10 micromol/l in the last week before delivery).
- You are taking a medicine called ursodeoxycholic acid (brand names include Actigall or Urso).
- Your baby will be born at or transferred within the first 24 hours to the Clinical Hospital of Obstetrics and Gynecology 'Prof.Dr. Panait Sirbu'.
- You give permission (informed consent) a few hours before giving birth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at bile acid levels in pregnant women who have intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes itching and can affect the baby. It also includes two control groups: healthy pregnant women and healthy non-pregnant women for comparison.
This study looks at bile acid levels and possible genetic changes in people with persistent pregnancy itching. The goal is to better understand the cause of intrahepatic cholestasis of pregnancy and related pregnancy outcomes.
This study tests a medication called maralixibat to see if it is safe and well-tolerated in pregnant women with intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes severe itching. Participation may help manage your symptoms and provide important information about this potential treatment.
This study tests a medication called maralixibat for treating intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes severe itching and can affect the baby. The goal is to see if it safely lowers bile acids and improves outcomes for you and your baby.
This study looks at whether a pregnancy liver condition called intrahepatic cholestasis of pregnancy is linked with chronic inflammation in the placenta. It may help doctors better understand risks and what to monitor during pregnancy.
This study follows babies under 6 months old who have early signs of liver disease (cholestasis) to better understand what causes it and how it progresses. Researchers will collect medical information over time to improve diagnosis and treatment.
Hear when a new Intrahepatic Cholestasis of Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.